Mental Health & Neurology
Post-Doctoral Fellowships
Switzerland
Testing changes in olfactory processing as a biomarker of mood disorders- a multidisciplinary study
Dr. Kalliopi Apazoglou is investigating the underexplored relationship between mood disorders and the brain’s olfactory system. Since feelings and smells have been shown to activate the same brain areas, she wants to know if a malfunction in these regions during a mood disorder causes changes in odor perception. Her preliminary data from imaging patients’ brains shows that when people with high depression scores smell different scents, there is less activity than normal in a specific brain region, as if its response to odors is blunted. But do parallels exist between olfactory function, personality traits and emotional state? To find out, she is measuring people’s reactions to different odors and correlating them with the results of behavioral questionnaires. She has found, for instance, that anxiety and emotional reactivity have a significant impact on the way people rate the pleasantness of odors, intensifying how much they like or dislike a scent. Dr. Apazoglou’s research aims at unraveling the mechanisms underlying olfaction and mood disorders. She hopes to contribute to both the prevention and diagnosis of depression, a condition that strikes up to 20% of the world’s population.
A Depressed Sense of Smell?
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Kalliopi
APAZOGLOU
Institution
University of Geneva
Country
Switzerland
Nationality
Greek
Related articles
Mental Health & Neurology
Pandemics & Infectious Diseases
Joint Research Initiative
Belgium
Towards a Sustainable Return to Work after Burnout or Depression
The COVID-19-crisis is likely to impact even further the number of people suffering from such disorders and their return to... Read more
Lode
GODDERIS
University of KU Leuven
Mental Health & Neurology
Women's Health
Pandemics & Infectious Diseases
AXA Award
Spain
The Effects of the COVID-19 Pandemic on the Mental Health of Mothers and Newborns
Early results are expected in less than 12 months and will help bridge a critical gap in research. Indeed, “in... Read more
Maria
FORASTER
ISGlobal Barcelona Institute for Global Health
Mental Health & Neurology
Pandemics & Infectious Diseases
AXA Award
Spain
Coping With the Pandemics: What Works Best to Reduce Anxiety & Depression
The results of this longitudinal study will allow Dr. Radua to produce evidence-based, clear, and specific recommendations on effective coping... Read more
Joaquim
RADUA